Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Mesoblast Limited ABN/ARBN Financial year ended: 68 109 431 870 30 June 2026 Our corporate governance...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Mesoblast
- Ceasing to be a substantial holder
- Becoming a substantial holder
- FDA Approves New Potency Assay for Commercial Ryoncil
- Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)
- Mesoblast Reports Substantial Revenue Growth to US$120M
Later from Mesoblast
- Notice of Annual General Meeting and Proxy Form
- Annual Report to Shareholders
- Application for quotation of securities - MSB
- Notification regarding unquoted securities - MSB
- Notification of cessation of securities - MSB
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast